In this issue:
Integrated clinical and proteomic characteristics analysis for CD with concomitant psoriasis
Self-management programme for fatigue, pain and faecal incontinence in IBD
Vedolizumab in early vs. late CD
SOR102, a TNF and IL-23 inhibitor, for UC
Induction and maintenance etrasimod for moderate-to-severe UC in East Asia
AI analysis of neutrophils to assess UC activity and early response to therapy
Mechanism-based psychological intervention for persistent GI symptoms in UC and IBS
Biologic dose escalation and de-escalation in IBD
VARSITY trial outcomes for low endoscopic burden but active histology vs. ‘conventional’ mild–moderate UC
Infliximab rescue concentrations and clearance for predicting outcomes in acute severe UC
Please login below to download this issue (PDF)